Zydus Sunshine Lifesciences to Invest Over USD 20 Million in Sri Lanka Pharma Manufacturing Facility
The plant will make oral solid dosage forms for the Sri Lankan market, with commercial operations planned for 2028.
7 Articles
7 Articles
Zydus Sunshine Lifesciences to Invest Over USD 20 Million in Sri Lanka Pharma Manufacturing Facility
New Delhi: Zydus Sunshine Lifesciences (Pvt) Ltd, a proposed joint venture between Zydus Lifesciences Limited (Zydus) and Sunshine Healthcare, part of Sunshine Holdings PLC, has signed an agreement...
Zydus Sunshine Lifesciences partners with BOI to launch a $20 million pharmaceutical manufacturing plant in Horana.
A new collaboration between Zydus Lifesciences Limited, a leading global life sciences firm based in India, and Sunshine Healthcare, a division of Sunshine Holdings PLC, […] The post Zydus Sunshine Lifesciences partners with BOI to launch a $20 million pharmaceutical manufacturing plant in Horana. appeared first on FINANCIAL CHRONICLE.
Zydus Lifesciences Rises 2% on Sri Lanka Plant Deal
Zydus Lifesciences shares rose 2% to a day high of Rs 1,150.80 on 15 October after its Sri Lanka venture signed a new plant deal. In a filing to the exchanges at 11:30 am, the company said Zydus Sunshine Lifesciences, a venture it is forming with Sunshine Healthcare, signed a...
Zydus Life surges as its JV inks pact to set up pharmaceutical manufacturing facility in Sri Lanka
Mumbai, October 15 (Udaipur Kiran): Zydus Lifesciences is currently trading at Rs. 1143.10, up by 19.10 points or 1.70% from its previous closing of Rs. 1124.00 on the… Zydus Life surges as its JV inks pact to set up pharmaceutical manufacturing facility in Sri Lanka
Coverage Details
Bias Distribution
- 34% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium









